双成药业
(002693)
| 流通市值：36.91亿 | | | 总市值：37.24亿 |
| 流通股本：4.11亿 | | | 总股本：4.15亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 117,157,787.26 | 48,439,867.75 | 276,761,196.91 | 168,903,838.01 |
| 营业总成本 | 111,712,392.98 | 50,126,030 | 267,592,610.62 | 180,108,046.32 |
| 其他经营收益 | | | | |
| 营业利润 | 8,984,089.52 | -523,509.47 | 8,859,787.46 | -7,394,530.37 |
| 利润总额 | 8,876,045.55 | -598,936.97 | 8,155,669.25 | -7,538,875.32 |
| 净利润 | 8,927,082.37 | -598,936.97 | 8,920,080.67 | -7,266,600.99 |
| 每股收益 | | | | |
| 其他综合收益 | -2,217.92 | -1,457.51 | 4,281.36 | 6,528.92 |
| 综合收益总额 | 8,924,864.45 | -600,394.48 | 8,924,362.03 | -7,260,072.07 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 194,231,124.03 | 199,537,770.14 | 204,713,984.45 | 178,818,753.97 |
| 非流动资产: | | | | |
| 非流动资产合计 | 616,316,984.64 | 616,603,177.57 | 621,061,298.32 | 618,951,717.96 |
| 资产总计 | 810,548,108.67 | 816,140,947.71 | 825,775,282.77 | 797,770,471.93 |
| 流动负债: | | | | |
| 流动负债合计 | 313,038,622.23 | 303,318,590.4 | 306,832,361.53 | 207,189,206.37 |
| 非流动负债: | | | | |
| 非流动负债合计 | 68,054,610.7 | 92,892,740.5 | 98,412,909.95 | 186,235,688.37 |
| 负债合计 | 381,093,232.93 | 396,211,330.9 | 405,245,271.48 | 393,424,894.74 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 426,082,987.15 | 415,904,171.26 | 412,457,416.68 | 390,893,020.73 |
| 股东权益合计 | 429,454,875.74 | 419,929,616.81 | 420,530,011.29 | 404,345,577.19 |
| 负债和股东权益合计 | 810,548,108.67 | 816,140,947.71 | 825,775,282.77 | 797,770,471.93 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 146,341,191.81 | 74,604,484.66 | 269,587,257.57 | 191,244,462.63 |
| 经营活动现金流出小计 | 125,828,912 | 54,409,715.48 | 208,637,981.92 | 159,162,689.56 |
| 经营活动产生的现金流量净额 | 20,512,279.81 | 20,194,769.18 | 60,949,275.65 | 32,081,773.07 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,440,150 | 700,190 | 200,942,993.94 | 171,289,193.46 |
| 投资活动现金流出小计 | 31,308,660.34 | 19,723,584.9 | 242,869,400.18 | 222,679,216.19 |
| 投资活动产生的现金流量净额 | -27,868,510.34 | -19,023,394.9 | -41,926,406.24 | -51,390,022.73 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 11,952,400 | 10,000,000 | 37,492,940 | 28,993,610 |
| 筹资活动现金流出小计 | 27,622,065.22 | 3,810,634.71 | 42,613,875.81 | 26,378,899.6 |
| 筹资活动产生的现金流量净额 | -15,669,665.22 | 6,189,365.29 | -5,120,935.81 | 2,614,710.4 |
| 汇率变动对现金及现金等价物的影响 | -2,005,925.39 | -682,323.89 | 42,503.86 | 287,184.1 |
| 现金及现金等价物净增加额 | -25,031,821.14 | 6,678,415.68 | 13,944,437.46 | -16,406,355.16 |
| 期末现金及现金等价物余额 | 34,018,458.62 | 65,728,695.44 | 59,050,279.76 | 28,699,487.14 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -25,031,821.14 | - | 13,944,437.46 | - |